Japan · Delayed Price · Currency is JPY Mizuho Medy Statistics
Total Valuation
Mizuho Medy has a market cap or net worth of JPY 31.53 billion. The enterprise value is 18.99 billion.
| Market Cap | 31.53B |
| Enterprise Value | 18.99B |
Important Dates
The next confirmed earnings date is Wednesday, August 12, 2026.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | Jun 29, 2026 |
Share Statistics
Mizuho Medy has 19.05 million shares outstanding. The number of shares has decreased by -11.11% in one year.
| Current Share Class | 19.05M |
| Shares Outstanding | 19.05M |
| Shares Change (YoY) | -11.11% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 28.58% |
| Owned by Institutions (%) | 4.86% |
| Float | 13.12M |
Valuation Ratios
The trailing PE ratio is 9.70.
| PE Ratio | 9.70 |
| Forward PE | n/a |
| PS Ratio | 2.91 |
| PB Ratio | 1.72 |
| P/TBV Ratio | 1.72 |
| P/FCF Ratio | 18.53 |
| P/OCF Ratio | 16.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.17, with an EV/FCF ratio of 11.16.
| EV / Earnings | 5.84 |
| EV / Sales | 1.76 |
| EV / EBITDA | 4.17 |
| EV / EBIT | 4.43 |
| EV / FCF | 11.16 |
Financial Position
The company has a current ratio of 11.59
| Current Ratio | 11.59 |
| Quick Ratio | 9.75 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 18.40% and return on invested capital (ROIC) is 45.35%.
| Return on Equity (ROE) | 18.40% |
| Return on Assets (ROA) | 13.03% |
| Return on Invested Capital (ROIC) | 45.35% |
| Return on Capital Employed (ROCE) | 22.12% |
| Weighted Average Cost of Capital (WACC) | 6.94% |
| Revenue Per Employee | 56.06M |
| Profits Per Employee | 16.83M |
| Employee Count | 193 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 1.30 |
Taxes
In the past 12 months, Mizuho Medy has paid 1.25 billion in taxes.
| Income Tax | 1.25B |
| Effective Tax Rate | 27.70% |
Stock Price Statistics
The stock price has increased by +16.06% in the last 52 weeks. The beta is 0.49, so Mizuho Medy's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +16.06% |
| 50-Day Moving Average | 1,678.56 |
| 200-Day Moving Average | 1,727.57 |
| Relative Strength Index (RSI) | 43.41 |
| Average Volume (20 Days) | 69,035 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mizuho Medy had revenue of JPY 10.82 billion and earned 3.25 billion in profits. Earnings per share was 170.56.
| Revenue | 10.82B |
| Gross Profit | 7.43B |
| Operating Income | 4.28B |
| Pretax Income | 4.49B |
| Net Income | 3.25B |
| EBITDA | 4.56B |
| EBIT | 4.28B |
| Earnings Per Share (EPS) | 170.56 |
Balance Sheet
The company has 12.54 billion in cash and no debt, with a net cash position of 12.54 billion or 658.15 per share.
| Cash & Cash Equivalents | 12.54B |
| Total Debt | n/a |
| Net Cash | 12.54B |
| Net Cash Per Share | 658.15 |
| Equity (Book Value) | 18.33B |
| Book Value Per Share | 962.43 |
| Working Capital | 16.60B |
Cash Flow
In the last 12 months, operating cash flow was 1.96 billion and capital expenditures -255.00 million, giving a free cash flow of 1.70 billion.
| Operating Cash Flow | 1.96B |
| Capital Expenditures | -255.00M |
| Depreciation & Amortization | 275.50M |
| Net Borrowing | n/a |
| Free Cash Flow | 1.70B |
| FCF Per Share | 89.30 |
Margins
Gross margin is 68.63%, with operating and profit margins of 39.59% and 30.03%.
| Gross Margin | 68.63% |
| Operating Margin | 39.59% |
| Pretax Margin | 41.54% |
| Profit Margin | 30.03% |
| EBITDA Margin | 42.13% |
| EBIT Margin | 39.59% |
| FCF Margin | 15.11% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 5.96%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 5.96% |
| Dividend Growth (YoY) | -9.09% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 11.11% |
| Shareholder Yield | 17.07% |
| Earnings Yield | 10.31% |
| FCF Yield | 5.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 27, 2024. It was a forward split with a ratio of 2.
| Last Split Date | Jun 27, 2024 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Mizuho Medy has an Altman Z-Score of 10.41 and a Piotroski F-Score of 4.
| Altman Z-Score | 10.41 |
| Piotroski F-Score | 4 |